New data shows Alzheimer's drug can slow cognitive decline
Published
Promising data shows that an Alzheimer's drug can slow cognitive decline. In a phase III clinical trial, with results published Tuesday in the New England Journal of Medicine, the drug, Lecanemab -- developed by Eisai and Biogen Inc. -- slowed the rate of cognitive decline by 27% in patients in…
#alzheimerdisease #alzheimer #alzheimerdrug #lecanemab #drug #disease #alzheimerassociation #iiiclinical #yalealzheimer #impairment